FOXP4 and hepatocellular carcinoma: demonstrated that incomplete RFA promotes malignant progression via FOXP4-mediated induction of N-deacetylase and N-sulfotransferase 2 (NDST2), where FOXP4 knockdown suppresses tumor progression and NDST2 expression in residual HCC (487).